Vimarsana
Biggest News Aggregation in the World

Alpha Cognition Chart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alpha Cognition Chart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alpha Cognition Chart Today - Breaking & Trending Today

Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer's Disease Seite 1 - Vimarsana News

Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer's Disease Seite 1

22.02.2024 - Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announce that it has filed a new ... Seite 1

Alpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering - Vimarsana News

Alpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering

22.12.2023 - Alpha Cognition Inc. (CSE: ACOG, OTCQB: ACOGF) (“Alpha Cognition” or the “Company”) announces that it has completed a fourth closing pursuant to its previously announced private placement of units of the Company. Pursuant to the fourth closing, the ...

Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer's Disease Seite 1 - Vimarsana News

Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer's Disease Seite 1

27.09.2023 - Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announce the submission of a New Drug ... Seite 1